The Future of Chemotherapy Care: Reducing Hospital Admissions and ED Visits
A 10-pronged intervention strategy implemented in the healthcare field significantly reduced hospital admissions and emergency department (ED) visits by 16% following chemotherapy treatment, offering a beacon of hope for the future of oncology care management.
Understanding CMS OP-35 Measure
The Centers for Medicare & Medicaid Services (CMS) OP-35 measure focuses on preventing avoidable hospital admissions and ED visits after outpatient chemotherapy. This initiative evaluates conditions like anemia, dehydration, diarrhea, emesis, fever, nausea, neutropenia, pain, pneumonia, and sepsis within 30 days post-treatment, targeting only hospital-based infusion centers.
Joseph, a key speaker at the 50th Annual ONS Congress, explained, “That’s a large population. When you look at the cancer patients, just because [of age of diagnosis], our patients do become Medicare eligible much younger than 65 years old.” This insight into patient demographics highlights the broad reach and potential impact of such preventative measures.
Strategic Interventions Making a Difference
AdventHealth‘s strategic efforts to comply with CMS quality measures led to notable reductions in ED visits while spotlighting areas for improvement in hospital admissions post-chemotherapy.
- Education for providers and patients elucidates the core values of understanding adverse treatment effects and navigating the healthcare system effectively.
- Multidisciplinary care coordination ensures seamless communication across healthcare departments, a critical factor in patient outcomes.
- An oncology nurse hotline offers immediate support, a lifeline for patients experiencing troubling symptoms who might otherwise resort to emergency services.
- Same-day infusion appointments for outpatient symptom management at infusion centers, combined with home-based care solutions, exemplify a commitment to patient-centric care.
Pro Tip: Immediate Access is Key
Providing patients direct access to follow-up care and symptom management significantly reduces unnecessary emergency visits, enhancing overall patient satisfaction and outcomes.
The Role of Technology in Healthcare Innovation
Despite the success of these interventions, implementing new strategies isn’t without challenges. Staffing shortages, reporting complexities, and technological limitations often present barriers, underscoring the need for continued innovation in digital health solutions.
Real-World Impact: A Glimpse into the Future
Cases like AdventHealth’s model provide a robust framework for other healthcare institutions aiming to mitigate hospital and ED visits post-chemotherapy. By leveraging comprehensive care strategies, the shift towards increased outpatient management represents a promising evolution in cancer care.
Frequently Asked Questions about Chemotherapy Care Innovations
Q: What is the CMS OP-35 measure?
A: The CMS OP-35 is a quality measure assessing the prevention of avoidable hospital admissions and ED visits within 30 days of outpatient chemotherapy for specific conditions.
Q: How have 10-pronged interventions improved patient care?
A: By focusing on patient education, care coordination, and accessible support services, these interventions have reduced unnecessary hospital and ED visits, enhancing patient outcomes.
Engage with Us
Are you interested in learning more about healthcare innovations? Comment below with your thoughts, or subscribe to our newsletter for the latest articles and insights in healthcare advancements.
